Buyer Guide

How RxLabelGuard Compares

This comparison focuses on publicly documented capabilities as of March 6, 2026. It is intended for engineering evaluation, not medical advice.

openFDA Drug Label API

Best for
Public access to SPL-derived FDA drug label sections over REST.
Documentation confirms
openFDA publishes drug label fields (including drug_interactions text) and documents API key and rate-limit behavior.
Still needs implementation
Teams still need to normalize narrative label text into consistent severity/recommendation output for clinical workflows.

DailyMed Web Services

Best for
Official NLM distribution of drug labels and SPL source retrieval.
Documentation confirms
DailyMed exposes web services and downloadable SPL resources for label content and metadata.
Still needs implementation
SPL content still needs downstream parsing, entity resolution, and interaction extraction to become an application-ready API.

RxNorm / RxNav APIs

Best for
Medication normalization and identifier mapping (name to RxCUI, NDC mappings, and concept lookups).
Documentation confirms
RxNorm APIs are positioned as terminology and concept APIs, with endpoints focused on vocabulary lookup and mapping operations.
Still needs implementation
Normalization is foundational, but interaction evidence extraction and severity policy still require additional data and logic.

DrugBank API

Best for
Commercial drug-data API procurement for teams buying a managed proprietary dataset.
Documentation confirms
DrugBank describes its API as a commercial product and terms of use define contractual restrictions for use/access.
Still needs implementation
Procurement, legal review, and dataset-fit validation are typically required before production rollout.

Reference List

  1. openFDA Drug Label Endpoint (U.S. Food and Drug Administration (FDA); accessed March 6, 2026)

    Describes searchable SPL-derived labeling data, endpoint behavior, and key facts.

  2. openFDA Drug Label Searchable Fields (U.S. Food and Drug Administration (FDA); accessed March 6, 2026)

    Lists fields such as drug_interactions, contraindications, and warnings as searchable text fields.

  3. openFDA Authentication (U.S. Food and Drug Administration (FDA); accessed March 6, 2026)

    Documents optional API keys and published rate limits (240 requests/minute, 120,000 requests/day).

  4. DailyMed (U.S. National Library of Medicine (NLM); accessed March 6, 2026)

    Describes DailyMed as an official source for FDA label content in SPL format and related resources.

  5. DailyMed Web Services (U.S. National Library of Medicine (NLM); accessed March 6, 2026)

    Documents REST web services and downloadable SPL package access for label retrieval.

  6. How Do I Use Prescription Drug Labeling (U.S. Food and Drug Administration (FDA); accessed March 6, 2026)

    Describes structured USPI sections, including Section 7 (Drug Interactions), in FDA prescribing information.

  7. RxNav APIs (U.S. National Library of Medicine (NLM); accessed March 6, 2026)

    Overview of RxNav API families for medication terminology lookup and normalization tasks.

  8. RxNorm API (U.S. National Library of Medicine (NLM); accessed March 6, 2026)

    Defines RxNorm endpoints for concept IDs, name matching, properties, and NDC mappings.

  9. DrugBank API Product Page (DrugBank; accessed March 6, 2026)

    Public product documentation describing API access as a paid commercial offering.

  10. DrugBank Terms of Use (DrugBank; accessed March 6, 2026)

    Specifies commercial use terms and access restrictions for DrugBank offerings.